Endometrial Ablation

Five studies evaluating NovaSure system presented at AAGL meeting

Published in Cancer Weekly, December 14th, 2004

Cytyc Corp. (CYTC) announced that five studies evaluating safety, clinical performance, and ease-of-use for its NovaSure System for endometrial ablation were presented at the 33rd annual meeting of the American Association of Gynecologic Laparoscopists (AAGL) held in San Francisco, Calitornia.

The results indicate NovaSure is safe and effective in treating excessive menstrual bleeding in patients with Type I and Type II fibroids, compatible with an office setting, and that Essure hysteroscopic sterilization is achievable following the procedure.

A study by Tamas Fulop, MD, of St. Imre Teaching Hospital in Budapest, Hungary, performed a 5-year...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2004-12-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry